# TBAF-Promoted Carbanion-Mediated Sulfonamide Cyclization of CF 3 -substituted N-Allenamides: an Access to Fluorinated γ-Sultams

Clément Gommenginger, Yongxiang Zheng, Daniele Maccarone, Ilaria Ciofini, Laurence Miesch

► To cite this version:

Clément Gommenginger, Yongxiang Zheng, Daniele Maccarone, Ilaria Ciofini, Laurence Miesch. TBAF-Promoted Carbanion-Mediated Sulfonamide Cyclization of CF 3 -substituted N-Allenamides: an Access to Fluorinated γ-Sultams. Organic Chemistry Frontiers, 2023, 10, pp.4055-4060. 10.1039/x0xx00000x. hal-04253682

HAL Id: hal-04253682

https://hal.science/hal-04253682v1

Submitted on 23 Oct 2023

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
ARTICLE

# TBAF-Promoted Carbanion-Mediated Sulfonamide Cyclization of CF₃-substituted N-Allenamides: an Access to Fluorinated γ-Sultams

Received 00th January 20xx,
Accepted 00th January 20xx

DOI: 10.1039/x0xx00000x

Clément Gommengingerª, Yongxiang Zhengª, Daniele Maccaroneᵇ, Ilaria Ciofiniᵇ and Laurence Miesch*ª

Upon treatment with TBAF, CF₃-substituted N-allenamides were transformed into γ-sultams. Cyclic sulfonamides bearing an ene-gem-difluorinated tether could be obtained by addition of acetic acid to the ammonium salt whereas TBAF alone provided the corresponding trifluorinated ethyl sultams. A combined experimental and computational mechanistic study suggested that this transformation involves a 5-endo-dig cyclization on the ene-ynamide generated in situ.

## Introduction

Since the discovery of sulfonamide antibacterials,¹ sulfonamides have played a key role in medicinal chemistry. The cyclic counterparts of sulfonamide compounds (sultams) display enhanced biological activities compared to their acyclic congeners.² Although not found in nature, these amide surrogates are considered privileged motifs that have found diverse applications in drug discovery such as in sultiam, an anticonvulsant agent,³ S-2474, a non-steroidal anti-inflammatory drug,⁴ tauroolidine, which exhibits antimicrobial and anticancer activities,⁵ a naphthyridine derivative that is an HIV-1 inhibitor,⁶ and an antidiabetes agent developed by Boehringer Ingelheim.⁷

<figure><img src="image_2.png" /><figcaption>Fig. 1 Biologically active sultams</figcaption></figure>

In view of this important structural motif, numerous methods for their synthesis have been developed. The carbanion-

mediated sulfonate (or sulfonamide) cyclization constitutes a well-known approach to these important scaffolds (Scheme 1, A).⁸

<figure><img src="image_3.png" /></figure>

<figure><img src="image_4.png" /></figure>

<figure><img src="image_5.png" /><figcaption>Scheme 1 Synthetic Routes to γ-Sultams</figcaption></figure>

In this process, the carbanion resulting from deprotonation of the proton located at the α-position of the SO₂ group reacts with a suitable electrophile to form various cyclic

<footnote>ªEquipe Synthèse Organique et Phytochimie, Institut de Chimie, CNRS-UdS, UMR 7177, 4 rue Blaise Pascal, CS 90032, 67081, Strasbourg, France. E-mail: lmiesch@unistra.fr</footnote>

<footnote>ᵇChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Chemical Theory and Modelling Group, F-75005 Paris, France</footnote>

<footnote>†Electronic Supplementary Information (ESI) available: See</footnote>

<footnote>DOI: 10.1039/x0xx00000x</footnote>
sulfonamides. Intramolecular Diels-Alder cycloadditions of vinylsulfonamides have proven to be essential to construct specific sultams (Scheme 1, B).⁹ Although effective, these protocols require strong bases and harsh reaction conditions often detrimental to sensitive functional groups. Transition-metal catalyzed-processes,¹⁰ including intramolecular Heck reactions of α-bromovinylsulfonamides,¹¹ rhodium-catalyzed intramolecular aziridination of unsaturated sulfonamides,¹² as well as ring-closing metathesis,¹⁰, ¹³ have emerged as powerful methods to prepare cyclic sulfonamides (Scheme 1, C). Recently, Mykhailiuk reported a photochemical cyclization providing access to a new class of bicyclic sultams (Scheme 1, D).¹⁴ Because organofluorine compounds play a critical role in life science and agrochemistry, the judicious introduction of fluorine atoms into organic molecules has become an increasingly dominant research area.¹⁵ In particular, the gem-difluoro-ene group, a mimic of carbonyl compounds,¹⁶ and the CF₃ moiety are attractive targets because of their impact on the development of marketed drugs.¹⁷

In view of our previous results on CF₃-substituted N-allenamides, we anticipated that deprotonation at the α-position of the sulfonyl moiety of N-sulfonyl-allenamides might initiate an anionic 5-endo-dig cyclization to produce cyclic sulfonamides.

We report herein a *n*-tetrabutylammonium fluoride (TBAF)-promoted cyclization of CF₃-substituted *N*-sulfonyl-allenamides for the preparation of trifluoethyl-substituted and difluoro-ene sultams (Scheme 1). Trifluoromethylated *N*-allenamides were obtained by treatment of terminal ynamides with trifluoromethylated diazomethane according to our previously developed strategy.¹⁸

## Results and discussion

In consideration of the work of Cui *et al.*, who observed an unusual reorganization divergence on *N*-sulfonyl ynamides upon basic treatment via a 4-exo-dig cyclization and subsequent 1,3 sulfonyl-migration¹⁹ (Scheme 1, E), we performed our first experiment by treatment of trifluoromethylated *N*-allenamide **1a** with lithium diisopropylamide (LDA) in THF. In this case, only the corresponding *ene*-ynamide **6** was observed along with some stating material (Table 1, entry 1).²⁰ By employing weaker bases such as Cs₂CO₃, the starting material was totally recovered (Table 1, entry 2). Taking into consideration these results, we wondered whether tetraalkyl ammonium fluoride salts would provide an efficient solution to this problem. When TBAF was employed as a base, we noticed that a mixture of two cyclic unsaturated sulfonamides, a CF₃-substituted and an ene-difluorinated sultam, **3a** and **2a**, respectively, were isolated along with some starting material **1a** (Table 1, entry 3). By increasing the amount of TBAF, this transformation was exclusively directed toward the formation of CF₃-substituted sultam **3a** (Table 1, entry 4). To guide the reaction solely toward the difluorinated ene product **2a**, our objective was to quench the released fluoride ion with an acid to avoid the re-introduction of the fluoride ion on the difluorinated ene moiety.²⁰

First trials were carried out with a Lewis acid. Whether with BF₃·Et₂O, TMSOTf, or FeCl₃ (Table 1, entries 5-7), the outcome of this transformation led to a mixture of compounds **2a** and **3a**, albeit the selectivity is poorer with the latter. We then turned our attention to the utilization of a Brønsted acid. Triflic acid (TfOH) and trifluoroacetic acid (TFA) led to a mixture of sultams **2a** and **3a**, whereas acetic acid provided the desired difluorinated ene-sultam **2a** with 69% yield along with traces of the trifluorinated derivative **3a** (Table 1, entries 8-10). Controlled experiments with Brønsted acids such as TFA and TfOH alone led to degradation of the starting material (Table 1, entries 11-12), whereas with acetic acid the starting material was totally recovered (Table 1, entry 13). When CF₃-substituted *N*-allenamide **1a** was subjected to hydrofluoric acid (HF), the corresponding mesylsulfonamide was exclusively isolated (Table 1, entry 14).

<table><caption>**Table 1** Optimization.</caption><thead><tr><th rowspan="2">Entry<sup>a</sup></th><th rowspan="2">Base<br>([equiv])</th><th rowspan="2">Acid<br>([equiv])</th><th colspan="3">Yield [%]<sup>b</sup></th></tr><tr><th>2a</th><th>3a</th><th>1a</th></tr></thead><tbody><tr><td>1<sup>c</sup></td><td>LDA (1.2)</td><td>-</td><td>-</td><td>-</td><td>30</td></tr><tr><td>2</td><td>Cs<sub>2</sub>CO<sub>3</sub><br>(1.2)</td><td>-</td><td>-</td><td>-</td><td>100</td></tr><tr><td>3<sup>d</sup></td><td>TBAF (1)</td><td>-</td><td>14</td><td>41</td><td>27</td></tr><tr><td>4</td><td>TBAF (5)</td><td>-</td><td>-</td><td>57</td><td>-</td></tr><tr><td>5</td><td>TBAF (5)</td><td>BF<sub>3</sub>·OEt<sub>2</sub><br>(3)</td><td>55</td><td>13</td><td>n.d.</td></tr><tr><td>6</td><td>TBAF (5)</td><td>TMSOTf<br>(1.2)</td><td>43</td><td>7</td><td>37</td></tr><tr><td>7</td><td>TBAF (5)</td><td>FeCl<sub>3</sub> (5)</td><td>35</td><td>26</td><td>n.d.</td></tr><tr><td>8</td><td>TBAF (5)</td><td>TfOH (4.5)</td><td>45</td><td>11</td><td>-</td></tr><tr><td>9</td><td>TBAF (5)</td><td>TFA (2.5)</td><td>36</td><td>26</td><td>-</td></tr><tr><td>10</td><td>TBAF (5)</td><td>AcOH (5)</td><td>69</td><td>traces</td><td>-</td></tr><tr><td>11<sup>e</sup></td><td>-</td><td>TFA (5)</td><td>-</td><td>-</td><td>-</td></tr><tr><td>12<sup>e</sup></td><td>-</td><td>TfOH (5)</td><td>-</td><td>-</td><td>-</td></tr><tr><td>13</td><td>-</td><td>AcOH (5)</td><td>-</td><td>-</td><td>>98</td></tr><tr><td>14<sup>f</sup></td><td>-</td><td>HF (cat.)</td><td>-</td><td>-</td><td>-</td></tr></tbody></table>

a Reaction conditions: to a solution of **1a** (0.25 mmol) in THF (2 mL), was added a solution of TBAF (1 M in THF, 1.25 mmol) at 23 °C, and the mixture was stirred for 18 h. b Isolated yields. c The mixture was stirred from -78 °C to 0 °C for 1 day. The corresponding *ene*-ynamide **6** was observed in mixture with **1a**. d The mixture was stirred for 1 h instead 18 h. e Only degradation of starting material was observed. f 94% of mesylsulfonamide was isolated.

Under the optimized conditions, the reaction scope of this 5-endo-dig cyclization was examined. First, we investigated the chemical space of the unsaturated *ene*-difluorinated sultams. Linear alkyls (2b) and cyclic alkyls (2c-e) were tolerated for this transformation. Aryl substituents (2a-j) were accommodated as well. Pleasingly, functionalized sidechains suitable for late-stage transformations could be installed on the sultam ring through this transformation. In particular, unsaturated sidechains (2k-2l), protected aldehydes (2m), di- and trifluorinated sidechains (2n-o), and ferrocenyl derivatives (2p)²¹ were successfully adapted (Scheme 4). X-Ray analysis of 2p
confirmed the structure of the difluoro-ene sultam (CCDC 2259326 contains the supplementary crystallographic data for the structure).²²

<figure><img src="image_6.png" /><figcaption>**Scheme 4** Scope of the synthesis gem-difluorinated y-sultams</figcaption></figure>

We then focused on access of the unsaturated sultams to products bearing a CF₃-tether. Aryl derivatives (3a-e), unsaturated sidechains (3f), di-fluorinated sidechains (3g), as well as tryptamine derivatives (3h) could be adapted, albeit with lower yields because of instability of the targeted compounds (Scheme 5).

<figure><img src="image_7.png" /><figcaption>**Scheme 5** Scope of the synthesis trifluorinated y-sultams</figcaption></figure>

To gain greater insight into the reaction mechanism, a series of control experiments were performed. When the difluorinated substrate **1a** was exposed to the same reaction conditions, i.e., TBAF/AcOH, the corresponding sultam was not observed; the monofluorinated ene-ynamide **5** was exclusively obtained in

88% yield as a 3:1 mixture of E- and Z- compounds. We have recently demonstrated that gem-difluorinated ene-ynamides **6** could be obtained directly through base-induced treatment of trifluoromethylated N-allenamides.²⁰

Additionally, when the difluorinated ene-ynamide **6** was treated under the same conditions (i.e., a mixture of TBAF and AcOH) the corresponding ene- difluorinated sultam **2a** was obtained, providing evidence that the ene-ynamide species **6** is an intermediate of the transformation.

It is also possible to achieve the synthesis of CF₃-substituted sultam **3a** directly from the ene- difluorinated sultam **2a**, which reinforces the theory that the fluoride ion must be quenched to access to sultams bearing an ene-difluorinated tether.²³

<figure><img src="image_8.png" /><figcaption>**Scheme 6** Mechanistic Insights</figcaption></figure>

Based on the aforementioned experimental results, calculations based on Density Functional Theory (DFT) were performed to provide support for a plausible reaction mechanism. A simplified reaction scheme is depicted in **Scheme 7**, while the full computed reaction profile is reported in **Scheme 8**. Thanks to the presence of fluoride ions in the reaction medium, the N-allenamide **1-A** is deprotonated α to the nitrogen, thus allowing a subsequent δ-elimination of a fluoride ion, providing difluorinated ene-ynamide **2-A**. This is consistent with the formation of compound **5** (Scheme 6). Ylide **3-A** is generated *in situ* through an HF-catalyzed process.²⁴ 5-endo-dig Addition of ylide **3-A** on the ynamide part of the molecule provides y-sultam with a gem-difluorinated ene-tether **4-A**. Further addition of the fluoride ion on compound **4-A** led finally to the trifluorinated adduct **6-A via** compound **5-A** (Scheme 7).

<figure><img src="image_9.png" /><figcaption>**Scheme 7** Schematic representation of the proposed mechanism</figcaption></figure>
<figure><img src="image_10.png" /><figcaption>**Scheme 8** Computed reaction pathway (relatives energies in kcal/mol).</figcaption></figure>

The full computed energy profile reported in **Scheme 8** is more complex because of the formation of a larger number of reaction intermediates (refer to SI for Computational Details). Nonetheless, it reveals that the energetically demanding step is the deprotonation, with an energetic barrier of about 29 kcal/mol. Once the deprotonation has taken place, the reaction proceeds toward the thermodynamically more stable products with barriers all below 20 kcal/mol. It is also important to stress the role played by the F-/HF pair in stabilizing the different reaction intermediates and transition states (TS). Analysis of the evolution of the carbon-carbon bonds (reported in the ESI) along the molecular skeleton indicates that starting from the allene **1-A** (showing two C-C double bonds of 1.306 Å for the allene and single bond of 1.488 Å), a triple-(1.208 Å) single-(1.409 Å) and double bond (1.330 Å) are formed in intermediates **2-A** and **3-A** before the formation of the cyclic product.

From intermediate **3-A**, cyclization to yield a four-membered ring was also tested (see ESI). Nonetheless, the associated TS is higher in energy with respect to the corresponding one leading to the formation of the experimentally observed sultam, and the four-membered ring product is less stable than compound **4-A** by about 12 kcal/mol. Calculations performed on the analogous difluorinated substrate (see ESI) show that while the reaction barrier associated with the deprotonation of the proton α to the nitrogen is relatively similar, the transition state for the cyclization step is actually much higher (roughly 40 kcal/mol), thus impeding the formation of the corresponding sultam as experimentally observed.

## Conclusions

In conclusion, we have developed a mild and efficient access to trifluorinated- and ene-*gem*-difluorinated γ-sultams from $CF_3$-substituted *N*-allenamides. Addition of TBAF allowed the formation of $CF_3$-substituted sultams, whereas addition of acetic acid to the ammonium salt led to the formation of cyclic sulfonamides bearing a difluorinated ene moiety. The developed strategy shows broad functional group tolerance and a good substrate scope. Furthermore, DFT calculations corroborated a transformation proceeding by a 5-*endo*-dig cyclization on the ene-ynamide formed *in situ*.

## Data availability

All experimental data and detailed procedures, including computational details, are available in the ESI.

## Conflicts of interest

There are no conflicts to declare.

## Acknowledgements

Support for this work was provided by CNRS and Université de Strasbourg. C.G. thanks M.R.T. for a research fellowship, and Y.Z. thanks C.S.C for a research fellowship.

## Notes and references
1 J. E. Lesch, *The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine*, Oxford University Press, Oxford, 2007.

2 S. Debnath and S. Mondal, *Sultams: Recent Syntheses and Applications*, Eur. J. Org. Chem., 2018, 933-956.

3 K. M. Gorman and A. Shahwan, *Sultiame revisited: treatmentof refractory absence seizures*, *Epileptic Disord*, 2016, **18**, 329-330

4 M. Inagaki, T. Turi, H. Jyoyama, T. Ono, K. Yamada, M. Kobayashi, Y. Hori, A. Arimura, K. Yasui, K. Ohno, S. Kakudo, K. Koizumi, R. Suzuki, M. Kato, S. Kawai and S. Matsumoto, *Novel Antiarthritic Agents with 1,2-Isothiazolidine-1,1-dioxide (γ-Sultam) Skeleton: Cytokine Suppressive Dual Inhibitors of Cyclooxygenase-2 and 5-Lipoxygenase*, J. Med. Chem., 2000, **43**, 2040-2048.

5 (a) P. M. Neary, P. Hallihan, J. H. Wang, R. W. Pfirrmann, D. J. Bouchier-Hayes and H. P. Redmond, *The Evolving Role of Taurolidine in Cancer Therapy*, Ann. Surg. Oncol, 2010, **17**, 1135-1143. (b) Y. Liu, A-Q. Zhang, L. Cao, H-T. Xia and J-J. Ma, *Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials*, PLoS ONE, 2013, **8**, e79417.

6 L. Zhuang, J. S. Wai, M. W. Embrey, T. E. Fisher, M. S. Egbertson, L. S. Payne, J. P. Guare, J. P. Vacca, D. J. Hazuda, P. J. Felock, A. L. Wolfe, K. A. Stillmock, M. V. Witmer, G. Moyer, W. A. Schleif, L. J. Gabryelski, Y. M. Leonard, J. J. Lynch, S. R. Michelson and S. D. Young, *Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells*, J. Med. Chem., 2003, **46**, 453-456.

7 D. A. Claremon, L. Zhuang, K. Leftheris, C. M. Tice, Y. Ye, S. B. Singh and F. Himmelsbach, *Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1*, 2013, US 8,592,410 B2

8 (a) D. Postel, A. N. Van Nhien and J. L. Marco, *Chemistry of Sulfonate- and Sulfonamide-Stabilized Carbanions* – The CSIC Reactions*, Eur. J. Org. Chem., 2003, 3713-3726. (b) A. V. Dobrydnev and J. Marco – Contelles, *Updating the CSIC Reaction* (2003–2020), Eur. J. Org. Chem., 2021, 1229-1248.

9 (a) P. Metz, D. Seng, R. Fröhlich and B. Wibbeling, *Intramolecular Diels-Alder Reactions of Vinylsulfonamides*, Synlett, 1996, 741-742. (b) A. D. Brosius, L. E. Overman and L. Schwink, *Total Synthesis of (+)-Aloperine*. Use of a Nitrogen-Bound Silicon Tether in an Intramolecular Diels-Alder Reaction*, J. Am. Chem. Soc., 1999, **121**, 700-709.

10 A. Zhou, D. Rayabarapu and P. R. Hanson, "Click, Click, Cyclize": A DOS Approach to Sultams Utilizing Vinyl Sulfonamide Linchpins, *Org. Lett.*, 2009, **11**, 531-534.

11 S. Merten, R. Fröhlich, O. Kataeva and P. Metz, *Synthesis of Sultams by Intramolecular Heck Reaction*, *Adv. Synth. Catal.*, 2005, **347**, 754-758.

12 J.-L. Liang, S.-X. Yuan, P. W. H. Chan and C.-M. Che, *Rhodium(II,II) Dimer as an Efficient Catalyst for Aziridination of Sulfonamides and Amidation of Steroids*, *Org. Lett.*, 2002, **4**, 4507-4510.

13 (a) S. Hanessian, H. Sailes and E. Therrien, *Synthesis of functionally diverse bicyclic sulfonamides as constrained proline analogues and application to the design of potential thrombin inhibitors*, *Tetrahedron*, 2003, **59**, 7047-7056. (b) S. Mondal and S. Debnath, *Synthesis of Sultams by Ring-Closing Metathesis*, *Synthesis*, 2014, **46**, 368-374.

14 D. Dibchak, V. Shcherbacova, A. V. Denisenko and P. K. Mykhailiuk, *Convenient Access to Conformationally Rigid Sultams*, *Org. Lett.*, 2019, **21**, 8909-8914.

15 (a) Bégué, J.-P.; Bonnet-Delpon, D. *Bioorganic and Medicinal Chemistry of Fluorine*; Wiley: Hoboken, NJ, 2008. (b) Hagmann, W.K., *The Many Roles for Fluorine in Medicinal Chemistry*, J. Med. Chem. 2008, **51**, 4359-4369. (c) Kirsch, P. *Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications*, 2nd ed.; Wiley-VCH, Weinheim, Germany, 2013.

16 Meanwell, N. A., *Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design*, J. Med. Chem., 2011, **54**, 2529-2591.

17 (a) J. Wang, M. Sánchez-Roselló, J. L. Aceña, C. del Pozo, A. E. Sorochinsky, S. Fustero, V. A. Soloshonok and H. Liu, *Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)*, Chem. Rev., 2014, **114**, 2432–2506. (b) H. Mei, J. Han, S. Fustero, M. Medio - Simon, D. M. Sedgwick, C. Santi, R. Ruzziconi and V. A., *Soloshonok, Fluorine-Containing Drugs Approved by the FDA in 2018*, Chem. Eur. J., 2019, **25**, 11797-11819.

18 Y. Zheng, B. Moegle, S. Ghosh, A. Perfetto, D. Luise, I. Ciofini and L. Miesch, *Copper-Catalyzed Synthesis of Terminal vs. Fluorine-Substituted N-Allenamides via Addition of Diazo Compounds to Terminal Ynamides*, Chem. Eur. J. 2022, **28**, e202103598.

19 L. Zeng, Y. Lin, J. Li, H. Sajiki, H. Xie and S. Cui, *Skeletal reorganization divergence of N-sulfonyl ynamides*, Nat Commun, 2020, **11**, 5639.

20 M. Hourtoule and L. Miesch, *Regio- and Stereoselective Addition to gem-Difluorinated Ene-Ynamides: Access to Stereodefined Fluorinated Dienes*, Org. Lett., 2022, **24**, 3896-3900.

21 C. Mahe, O. Blacque, G. Gasser, V. Gandon, and K. Cariou, *N-Metallocenyl Ynamides: Preparation, Reactivity, and Synthesis of ansa[3]-Ferrocenylamides*, Org. Lett., 2023, **25**, 624-629.

22 CCDC 2259326 (2p) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge crystallographic Data Centre.

23 Y. Qiao, T. Si, M.-H. Yang and R. A. Altman, *Metal-Free Trifluoromethylation of Aromatic and Heteroaromatic Aldehydes and Ketones*, J. Org. Chem., 2014, **79**, 7122-7131.

24 A. J. Mota, A. Klein, F. Wendling, A. Dedieu and M. Miesch, *Controlled Synthesis of α-Alenic Ester and Spiro Ketone Derivatives from Tailored α-Substituted Cycloalkanones Through Cascade Reactions: Exploring the Possible Reaction Pathways by Means of Semiempirical MO Calculations*, Eur. J. Org. Chem., 2005, 4346-4358.